Vitamin D Supplementation and Prevention of Type 2 Diabetes

Creative Commons License

AKTAŞ B. Y., Aktas O. O.

NEW ENGLAND JOURNAL OF MEDICINE, cilt.381, sa.18, ss.1784, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 381 Sayı: 18
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1056/nejmc1912185
  • Dergi Adı: NEW ENGLAND JOURNAL OF MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1784
  • Hacettepe Üniversitesi Adresli: Evet

Özet

To the Editor: In the randomized, placebo-controlled Vitamin D and Type 2 Diabetes (D2d) trial involving persons at risk for type 2 diabetes, Pittas et al. (Aug. 8 issue)(1) found that vitamin D-3 supplementation at a dose of 4000 IU per day did not result in a significantly lower risk of diabetes than placebo. Investigators emphasized that the trial was planned not only for participants with vitamin D insufficiency, given ethical considerations. Although the mean baseline vitamin D levels are well balanced between the trial groups and above insufficiency limits, more than 20% of the participants in the placebo group . . .